Pharming Group delivered strong financial results in Q4 2024 and provided an optimistic 2025 revenue guidance of $315 million ...

Pharming has taken a step closer to getting a second product to market, after its rare disease therapy leniolisib met its objectives in a pivotal trial, setting up regulatory filings in the coming ...

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a ...

Across the recent three months, 4 analysts have shared their insights on Pharming PHAR, expressing a variety of opinions spanning from bullish to bearish. The table below summarizes their recent ...

Pharming Group (NASDAQ:PHAR) has nominated Fabrice Chouraqui as its new Executive Director and CEO, succeeding Sijmen de Vries.The appointment will be for a four-year term, subject to shareholder ...

Explore Pharming stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHAR. G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems ...

A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website. For more information about these conferences ...

Pharming has submitted its oral phosphoinositide 3-kinase delta (PI3Kδ) inhibitor leniolisib for approval in the EU as a treatment for activated PI3K delta syndrome (APDS), an ultra-rare disease ...

Pharming Group N.V. Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the filing of its Annual ...

In this process plants are genetically modified so that they can produce medically useful substances such as drugs and vaccines. Plants such as corn, tobacco or rice can be genetically modified to ...

In this process plants are genetically modified so that they can produce medically useful substances such as drugs and vaccines. Plants such as corn, tobacco or rice can be genetically modified to ...